Authors
This author initiated 11 original pathways:
This author contributed to 102 pathways:
This author contributed to 102 pathways:
Marvin M2
Marvin Martens - Maastricht University
https://www.maastrichtuniversity.nl/marvin.martens
- GitHub: marvinm2
- ORCiD: 0000-0003-2230-0840
- Linked In: marvin-martens-451437131
- Google Scholar: GvOHiicAAAAJ&hl
- Wikidata: Q42369611
- Twitter: mmarvinm2
Communities
Adverse Outcome PathwaysPathways
This author initiated 11 original pathways:
This author contributed to 102 pathways:
This author contributed to 102 pathways:
- Thyroid hormones production and peripheral downstream signaling effects - WP4746 (Homo sapiens)
- Integrated breast cancer pathway - WP1984 (Homo sapiens)
- Hallmark of cancer: metastasis and epithelial-to-mesenchymal transition - WP5469 (Homo sapiens)
- miR-targeted genes in squamous cell - WP2006 (Homo sapiens)
- miR-targeted genes in muscle cell - WP2005 (Homo sapiens)
- miR-targeted genes in lymphocytes - WP2004 (Homo sapiens)
- Glycolysis - WP253 (Saccharomyces cerevisiae)
- Liver steatosis adverse outcome pathway - WP4010 (Homo sapiens)
- Pentose phosphate metabolism - WP134 (Homo sapiens)
- Phase I biotransformations, non-P450 - WP136 (Homo sapiens)
- Follicle stimulating hormone (FSH) signaling - WP2035 (Homo sapiens)
- DNA IR-double strand breaks and cellular response via ATM - WP3959 (Homo sapiens)
- 3q29 copy number variation syndrome - WP4906 (Homo sapiens)
- PI3K/AKT/mTOR - vitamin D3 signaling - WP4141 (Homo sapiens)
- Pathogenic Escherichia coli infection - WP2272 (Homo sapiens)
- Focal adhesion: PI3K-Akt-mTOR-signaling - WP3932 (Homo sapiens)
- GPR143 in melanocytes and retinal pigment epithelium cells - WP4941 (Homo sapiens)
- Calcium regulation in cardiac cells - WP536 (Homo sapiens)
- Activation of NLRP3 inflammasome by SARS-CoV-2 - WP4876 (Homo sapiens)
- Renin-angiotensin-aldosterone system (RAAS) - WP4756 (Homo sapiens)
- Fluoroacetic acid toxicity - WP4966 (Homo sapiens)
- Proximal tubule transport - WP4917 (Homo sapiens)
- 1q21.1 copy number variation syndrome - WP4905 (Homo sapiens)
- Nephrotoxcicity adverse outcome pathway - WP5229 (Homo sapiens)
- Thyroid hormone imbalance leading to neurodevelopmental abnormalities - WP5227 (Homo sapiens)
- ACE2 inhibition leads to pulmonary fibrosis - WP5035 (Homo sapiens)
- Genes associated with the development of rheumatoid arthritis - WP5033 (Homo sapiens)
- DNA adduct formation leading to kidney failure - WP5389 (Homo sapiens)
- Vitamin D-sensitive calcium signaling in depression - WP4698 (Homo sapiens)
- ESC pluripotency pathways - WP339 (Mus musculus)
- Acute viral myocarditis - WP4298 (Homo sapiens)
- Embryonic stem cell pluripotency pathways - WP3931 (Homo sapiens)
- Angiopoietin-like protein 8 regulatory pathway - WP3915 (Homo sapiens)
- Folate metabolism - WP176 (Homo sapiens)
- Frustrated phagocytosis leading to malignant pleural mesothelioma - WP5091 (Homo sapiens)
- Netrin-UNC5B signaling - WP4747 (Homo sapiens)
- Regulatory circuits of STAT3 signaling - WP4538 (Homo sapiens)
- Heart development - WP1591 (Homo sapiens)
- Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins - WP4936 (Homo sapiens)
- Arsenic liver toxicity pathway - WP5228 (Homo sapiens)
- Head and neck squamous cell carcinoma - WP4674 (Homo sapiens)
- Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome - WP4944 (Homo sapiens)
- Ethanol metabolism production of ROS by CYP2E1 - WP4269 (Homo sapiens)
- Ethanol metabolism resulting in production of ROS by CYP2E1 - WP4268 (Rattus norvegicus)
- RAS and bradykinin pathways in COVID-19 - WP4969 (Homo sapiens)
- Mitochondrial complex inhibition leading to liver injury - WP5034 (Homo sapiens)
- Kinin-Kallikrein pathway - WP5089 (Homo sapiens)
- Envelope proteins and their potential roles in EDMD physiopathology - WP4535 (Homo sapiens)
- Focal adhesion: PI3K-Akt-mTOR signaling pathway - WP2841 (Mus musculus)
- Overview of proinflammatory and profibrotic mediators - WP5095 (Homo sapiens)
- Angiotensin II receptor type 1 pathway - WP5036 (Homo sapiens)
- Evolocumab mechanism to reduce LDL cholesterol - WP3408 (Homo sapiens)
- Adverse outcome pathway for mitochondrial complex 1 (C1) inhibition - WP4914 (Homo sapiens)
- Striated muscle contraction pathway - WP383 (Homo sapiens)
- Vitamin B6-dependent and responsive disorders - WP4228 (Homo sapiens)
- Cellular proteostasis - WP4918 (Homo sapiens)
- Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway - WP4577 (Homo sapiens)
- Hippo-Merlin signaling dysregulation - WP4541 (Homo sapiens)
- Copper homeostasis - WP3286 (Homo sapiens)
- Apoptosis modulation and signaling - WP1772 (Homo sapiens)
- Prostaglandin signaling - WP5088 (Homo sapiens)
- EV release from cardiac cells and their functional effects - WP3297 (Homo sapiens)
- Methionine de novo and salvage pathway - WP3580 (Homo sapiens)
- Pleural mesothelioma - WP5087 (Homo sapiens)
- EGFR tyrosine kinase inhibitor resistance - WP4806 (Homo sapiens)
- Genetic alterations of lung cancer - WP1968 (Rattus norvegicus)
- Pre-implantation embryo - WP3527 (Homo sapiens)
- Integrated cancer pathway - WP1971 (Homo sapiens)
- Transcription factors regulate miRNAs related to cardiac hypertrophy - WP1559 (Homo sapiens)
- MicroRNAs in cardiomyocyte hypertrophy - WP1544 (Homo sapiens)
- Energy metabolism - WP1541 (Homo sapiens)
- Homologous recombination - WP186 (Homo sapiens)
- Mitochondrial complex I inhibition leading to parkinsonian motor deficits - WP4945 (Homo sapiens)
- Protein alkylation leading to liver fibrosis - WP3980 (Homo sapiens)
- Ethanol effects on histone modifications - WP3996 (Homo sapiens)
- Neuroinflammation - WP4919 (Homo sapiens)
- Selenium micronutrient network - WP15 (Homo sapiens)
- Leukocyte-intrinsic Hippo pathway functions - WP4542 (Homo sapiens)
- Melatonin metabolism and effects - WP3298 (Homo sapiens)
- Hormonal control of pubertal growth spurt - WP4194 (Homo sapiens)
- Host-pathogen interaction of human coronaviruses - MAPK signaling - WP4877 (Homo sapiens)
- ERK1-ERK2 MAPK cascade - WP402 (Danio rerio)
- Caffeine and theobromine metabolism - WP3633 (Homo sapiens)
- Differentiation of white and brown adipocyte - WP2895 (Homo sapiens)
- Mesodermal commitment pathway - WP2857 (Homo sapiens)
- Sphingolipid pathway - WP1422 (Homo sapiens)
- DNA repair pathways, full network - WP4946 (Homo sapiens)
- Mitochondrial complex IV assembly - WP4922 (Homo sapiens)
- Cell differentiation - expanded index - WP2023 (Homo sapiens)
- Monoterpene biosynthesis pathway in mint - WP4701 (Vitis vinifera)
- miRNA biogenesis - WP2338 (Homo sapiens)
- Ectoderm differentiation - WP2858 (Homo sapiens)
- One-carbon metabolism and related pathways - WP1770 (Mus musculus)
- Lactose degradation and galactose metabolism - WP546 (Saccharomyces cerevisiae)
- Disruption of postsynaptic signaling by CNV - WP4875 (Homo sapiens)
- Nanomaterial induced apoptosis - WP2507 (Homo sapiens)
- ErbB signaling pathway - WP1299 (Rattus norvegicus)
- ErbB signaling pathway - WP1261 (Mus musculus)
- Ethanol metabolism resulting in production of ROS by CYP2E1 - WP4265 (Mus musculus)
- Dopamine metabolism - WP2436 (Homo sapiens)
- G1 to S cell cycle control - WP445 (Danio rerio)
- SCFA and skeletal muscle substrate metabolism - WP4030 (Homo sapiens)